Nike (NKE.US) stock fell over 11.0% on Friday as better-than-expected quarterly results were overshadowed by excess inventory levels. Other retailers were also dragged down, with Lululemon Athletica (LULU.US) and Under Armour (UA.US) losing almost 6% and nearly 5% respectively.
- The sneaker and apparel maker reported Q1 revenue of $12.7 billion, up 4% YoY, beating market estimates of $12.27 billion. Company earned 93 cents per share, slightly above Wall Street consensus of 92 cents per share.
- However inventory on its balance sheet increased to 44% to $9.7 billion, driven by continued supply chain issues.
- As delivery times and consumer demand rose this year, retailers responded by ordering inventory earlier than usual. When in-transit shipping time improved significantly over the summer, it left Nike with excess inventories, CFO Matthew Friend said.
- In order to unwind the excess inventory, the company is planning to offer more discounts ahead of the holiday season, which only pushed stock price lower.
Nike (NKE.US) stock launched today's session with a massive bearish price gap and is currently trading below 78.6% Fibonacci retracement of the upward wave launched in March 2020 around $86.00. If sellers manage to break below the lower limit of the descending channel, then downward move may deepen towards pandemic lows at $60.70. Source: xStation5
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appThe material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.